C216H275ClN44O23S4 — CID 158978145
[1-[[2-(1,3-benzothiazol-2-yloxy)-4-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[1-[[3-(1,3-benzothiazol-2-yloxy)-5-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;N-[1-[4-[(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-3-yl]propanamide;[1-[[2-(1,1-dioxothian-4-yl)oxy-4-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[1-[[3-(1,1-dioxothian-4-yl)oxy-5-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;2-[3-methyl-5-[[8-[3-(prop-1-en-2-ylamino)pyrazole-1-carbonyl]-1,8-diazaspiro[4.5]decan-1-yl]methyl]phenoxy]-1-pyrrolidin-1-ylethanone;2-[5-methyl-2-[[8-[3-(prop-1-en-2-ylamino)pyrazole-1-carbonyl]-1,8-diazaspiro[4.5]decan-1-yl]methyl]phenoxy]-1-pyrrolidin-1-ylethanone;N-[1-[4-[(3-phenoxyphenyl)methyl]piperazine-1-carbonyl]pyrazol-3-yl]propanamide (PubChem CID 158978145) has the molecular formula C216H275ClN44O23S4 and a molecular weight of 4019.58 g/mol. Its IUPAC name is [1-[[2-(1,3-benzothiazol-2-yloxy)-4-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[1-[[3-(1,3-benzothiazol-2-yloxy)-5-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;N-[1-[4-[(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-3-yl]propanamide;[1-[[2-(1,1-dioxothian-4-yl)oxy-4-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[1-[[3-(1,1-dioxothian-4-yl)oxy-5-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;2-[3-methyl-5-[[8-[3-(prop-1-en-2-ylamino)pyrazole-1-carbonyl]-1,8-diazaspiro[4.5]decan-1-yl]methyl]phenoxy]-1-pyrrolidin-1-ylethanone;2-[5-methyl-2-[[8-[3-(prop-1-en-2-ylamino)pyrazole-1-carbonyl]-1,8-diazaspiro[4.5]decan-1-yl]methyl]phenoxy]-1-pyrrolidin-1-ylethanone;N-[1-[4-[(3-phenoxyphenyl)methyl]piperazine-1-carbonyl]pyrazol-3-yl]propanamide.
| Compound Name | [1-[[2-(1,3-benzothiazol-2-yloxy)-4-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[1-[[3-(1,3-benzothiazol-2-yloxy)-5-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;N-[1-[4-[(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-3-yl]propanamide;[1-[[2-(1,1-dioxothian-4-yl)oxy-4-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[1-[[3-(1,1-dioxothian-4-yl)oxy-5-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;2-[3-methyl-5-[[8-[3-(prop-1-en-2-ylamino)pyrazole-1-carbonyl]-1,8-diazaspiro[4.5]decan-1-yl]methyl]phenoxy]-1-pyrrolidin-1-ylethanone;2-[5-methyl-2-[[8-[3-(prop-1-en-2-ylamino)pyrazole-1-carbonyl]-1,8-diazaspiro[4.5]decan-1-yl]methyl]phenoxy]-1-pyrrolidin-1-ylethanone;N-[1-[4-[(3-phenoxyphenyl)methyl]piperazine-1-carbonyl]pyrazol-3-yl]propanamide |
|---|---|
| PubChem CID | 158978145 |
| Molecular Formula | C216H275ClN44O23S4 |
| Molecular Weight | 4019.58 g/mol |
| Exact Mass | 4016.03 |
| IUPAC Name | [1-[[2-(1,3-benzothiazol-2-yloxy)-4-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[1-[[3-(1,3-benzothiazol-2-yloxy)-5-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;N-[1-[4-[(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-3-yl]propanamide;[1-[[2-(1,1-dioxothian-4-yl)oxy-4-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[1-[[3-(1,1-dioxothian-4-yl)oxy-5-methylphenyl]methyl]-1,8-diazaspiro[4.5]decan-8-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;2-[3-methyl-5-[[8-[3-(prop-1-en-2-ylamino)pyrazole-1-carbonyl]-1,8-diazaspiro[4.5]decan-1-yl]methyl]phenoxy]-1-pyrrolidin-1-ylethanone;2-[5-methyl-2-[[8-[3-(prop-1-en-2-ylamino)pyrazole-1-carbonyl]-1,8-diazaspiro[4.5]decan-1-yl]methyl]phenoxy]-1-pyrrolidin-1-ylethanone;N-[1-[4-[(3-phenoxyphenyl)methyl]piperazine-1-carbonyl]pyrazol-3-yl]propanamide |
| SMILES | C=C(C)Nc1ccn(C(=O)N2CCC3(CCCN3Cc3cc(C)cc(OC4CCS(=O)(=O)CC4)c3)CC2)n1.C=C(C)Nc1ccn(C(=O)N2CCC3(CCCN3Cc3cc(C)cc(OCC(=O)N4CCCC4)c3)CC2)n1.C=C(C)Nc1ccn(C(=O)N2CCC3(CCCN3Cc3cc(C)cc(Oc4nc5ccccc5s4)c3)CC2)n1.C=C(C)Nc1ccn(C(=O)N2CCC3(CCCN3Cc3ccc(C)cc3OC3CCS(=O)(=O)CC3)CC2)n1.C=C(C)Nc1ccn(C(=O)N2CCC3(CCCN3Cc3ccc(C)cc3OCC(=O)N3CCCC3)CC2)n1.C=C(C)Nc1ccn(C(=O)N2CCC3(CCCN3Cc3ccc(C)cc3Oc3nc4ccccc4s3)CC2)n1.CCC(=O)Nc1ccn(C(=O)N2CCN(Cc3ccc(Cl)cc3)CC2)n1.CCC(=O)Nc1ccn(C(=O)N2CCN(Cc3cccc(Oc4ccccc4)c3)CC2)n1 |
| InChI | InChI=1S/2C30H34N6O2S.2C29H40N6O3.2C28H39N5O4S.C24H27N5O3.C18H22ClN5O2/c1-21(2)31-27-11-16-36(33-27)29(37)34-17-13-30(14-18-34)12-6-15-35(30)20-23-10-9-22(3)19-25(23)38-28-32-24-7-4-5-8-26(24)39-28;1-21(2)31-27-9-14-36(33-27)29(37)34-15-11-30(12-16-34)10-6-13-35(30)20-23-17-22(3)18-24(19-23)38-28-32-25-7-4-5-8-26(25)39-28;1-22(2)30-26-9-16-35(31-26)28(37)33-17-11-29(12-18-33)10-6-15-34(29)20-24-8-7-23(3)19-25(24)38-21-27(36)32-13-4-5-14-32;1-22(2)30-26-7-14-35(31-26)28(37)33-15-9-29(10-16-33)8-6-13-34(29)20-24-17-23(3)18-25(19-24)38-21-27(36)32-11-4-5-12-32;1-21(2)29-26-5-12-33(30-26)27(34)31-13-9-28(10-14-31)8-4-11-32(28)20-23-17-22(3)18-25(19-23)37-24-6-15-38(35,36)16-7-24;1-21(2)29-26-7-14-33(30-26)27(34)31-15-11-28(12-16-31)10-4-13-32(28)20-23-6-5-22(3)19-25(23)37-24-8-17-38(35,36)18-9-24;1-2-23(30)25-22-11-12-29(26-22)24(31)28-15-13-27(14-16-28)18-19-7-6-10-21(17-19)32-20-8-4-3-5-9-20;1-2-17(25)20-16-7-8-24(21-16)18(26)23-11-9-22(10-12-23)13-14-3-5-15(19)6-4-14/h4-5,7-11,16,19H,1,6,12-15,17-18,20H2,2-3H3,(H,31,33);4-5,7-9,14,17-19H,1,6,10-13,15-16,20H2,2-3H3,(H,31,33);7-9,16,19H,1,4-6,10-15,17-18,20-21H2,2-3H3,(H,30,31);7,14,17-19H,1,4-6,8-13,15-16,20-21H2,2-3H3,(H,30,31);5,12,17-19,24H,1,4,6-11,13-16,20H2,2-3H3,(H,29,30);5-7,14,19,24H,1,4,8-13,15-18,20H2,2-3H3,(H,29,30);3-12,17H,2,13-16,18H2,1H3,(H,25,26,30);3-8H,2,9-13H2,1H3,(H,20,21,25) |
| InChIKey | JOQOVISEAXIZDK-UHFFFAOYSA-N |
| XLogP | 36.61 |
| TPSA | 660.63 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 57 |
| Rotatable Bonds | 48 |
| Heavy Atoms | 288 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4019.58 |
| LogP ≤ 5 | 36.61 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 57 |